Disease progression among patients receiving tafamidis for transthyretin amyloidosis with cardiomyopathy in a real-world setting

Back

HFA Premium Access

Disease progression among patients receiving tafamidis for transthyretin amyloidosis with cardiomyopathy in a real-world setting

Session: Ambulatory care and monitoring in heart failure

Topic: Treatment

Speaker: Doctor D. Judge (Charleston, US)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Daniel Judge

Medical University of South Carolina, Charleston (United States of America)

0 follower

5 more presentations in this session

Baseline characteristics of patients with malnutrition or at risk of malnutrition and heart failure identified in the outpatient setting

Speaker: Doctor A. Esteban Fernandez (Leganes, ES)

Trends in care for ambulatory patients with heart failure at a large tertiary centre in England

Speaker: Doctor H. Ismail (Leeds, GB)

Effect of Cardiomems telemonitoring system on outcomes in patients with heart failure outside clinical trials: a systematic review and meta-analysis

Speaker: Doctor C. Kapelios (Athens, GR)

Gender differences in efficiency of the telemedicine care of heart failure patients.Tthe results from the TeleEducare-HF study

Speaker: Professor A. Bielecka-Dabrowa (Lodz, PL)

Targeted plasma profiling of the proteomic response to physical activity in heart failure with preserved ejection fraction

Speaker: Ms A. Kerber (Mainz, DE)

Access the full session

Ambulatory care and monitoring in heart failure

Speakers: Doctor D. Judge, Doctor A. Esteban Fernandez, Doctor H. Ismail, Doctor C. Kapelios, Professor A. Bielecka-Dabrowa...

Access

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources